Ultrasound monitoring of the surgical treatment effectiveness in patients with cervical and uterine cancers


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅或者付费存取

详细

Aim: The aim of the study was to determine ultrasound criteria for progression of cervical cancer and uterine cancer in patients after surgical and complex treatment with dynamic observation. Materials and methods: The study included 10 patients with diagnosis of cervical and uterine cancers. The patients underwent surgical and complex treatment. Standard and advanced ultrasound technologies were used to identify early progression of these diseases. Elastography for stiffness assessment was performed using ultrasound diagnostic systems Hitachi Arietta V70, Toshiba Aplio 500. Results: Based on the obtained results, a number of ultrasound-derived criteria for recurrences of cervical and uterine cancers as focal lesions after complex treatment were found. They allowed to detect suspected disease progression up to clinical manifestations. Differential diagnostics showed benign postoperative changes, and ultrasound examination showed their specific sighs. Additionally, ultrasound criteria were defined for the unchanged vaginal stump after surgical treatment. The signs were presented both in standard gray-scale mode and using advanced ultrasound technologies - elastography and stiffness measurements. Conclusion: Multiparametric ultrasound examination with standard grayscale imaging mode including elastography and stiffness assessment is a reliable way to improve the quality of preclinical diagnosis of recurrences and metastases of cervical and uterine cancers after complex treatment, as well as differential diagnosis of benign postoperative changes.

全文:

受限制的访问

作者简介

Marina Chekalova

Federal Scientific and Clinical Center for Special Types of Medical Care and Medical Technologies the Federal Medical-Biological Agency (FMBA) of Russia

Email: ch2me@yandexru
Dr. Med. Sci., Professor of the Department of Radiology and Ultrasound Diagnostics 115682, Russia, Moscow, Orekhov Boulevard, 28

Varvara Kryazheva

A.S. Loginov Moscow Clinical Scientific Center of Moscow Department of Health

Email: salvaje2005@yandex.ru
branch No. 1, Women's Health Clinic; PhD, doctor of ultrasound diagnostics 109240, Russia, Moscow, Goncharnaya str., 23

参考

  1. Аксель Е.М. Заболеваемость и смертность от злокачественных новообразований женской репродуктивной системы в России. Онкогинекология. 2015; 1: 8-9.
  2. Нечушкина В.М., Морхов К.Ю., Кузнецов В.В. Хирургическое лечение рака тела матки. Злокачественные опухоли. 2014; 3: 72-80.
  3. Manfredi R., Baltieri S., Tognolini A., Graziani R., Smaniotto D., Cellini N., Bonomo L. Reccurrent uterine cancer after surgery: magnetic resonance imaging patterns and their changes after concomitant chemoradiation. Radiol. Med. 2008; 113(8): 1143-56. https://dx.doi.org/10.1007/s11547-008-0312-3.
  4. Чиссов В.И., Давыдов М.И., ред. Онкология. Национальное руководство. М.: ГЭОТАР-Медиа; 2014.
  5. Kiss M.Z., Hobson M.A., Varghese T., Harter J., Kliewer M.A., Hartenbach E.M., Zagzebski J.A. Frequency-dependent complex modulus of the uterus: preliminary results. Phys. Med. Biol. 2006; 51(15): 3683-95. https://dx.doi.org/10.1088/0031-9155/51/15/006.
  6. Гажонова В.Е., Белозерова И.С., Воронцова Н.А., Титов Д.С. Соноэластография в диагностике рака эндометрия. Акушерство и гинекология. 2014; 1: 54-8.

补充文件

附件文件
动作
1. JATS XML

版权所有 © Bionika Media, 2022
##common.cookie##